265 related articles for article (PubMed ID: 4479789)
1. The effect of the nitrophenyl-dimethyl-dihydropyridine derivative nifedipine on intercoronary collateral circulation.
Kanazawa T; Suzuki N; Ino-oka E; Takahashi T; Mori A
Arzneimittelforschung; 1974 Sep; 24(9):1267-74. PubMed ID: 4479789
[No Abstract] [Full Text] [Related]
2. [Development of coronary collaterals following oral long-term therapy with nifedipine. Increased survival time following experimental coronary occlusion].
van Ackern K; Braasch W; Brückner UB; Heger W; Schmier J
Arzneimittelforschung; 1974 Oct; 24(10):1577-81. PubMed ID: 4479765
[No Abstract] [Full Text] [Related]
3. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
[No Abstract] [Full Text] [Related]
4. [The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man].
Kochsiek K; Neubaur J
Arzneimittelforschung; 1972 Feb; 22(2):353-8. PubMed ID: 5067487
[No Abstract] [Full Text] [Related]
5. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
Raff WK; Kosche F; Lochner W
Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
[No Abstract] [Full Text] [Related]
6. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
[No Abstract] [Full Text] [Related]
7. Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator.
Murakami M; Murakami E; Takekoshi N; Tsuchiya M; Kin T
Jpn Heart J; 1972 Mar; 13(2):128-35. PubMed ID: 4537344
[No Abstract] [Full Text] [Related]
8. [Acute action of nifedipine on the heart and circulation of dogs before and after oral long-term treatment].
van Ackern K; Braasch W; Brückner UB; Hakimi B; Schmier J; Simo I
Arzneimittelforschung; 1974 Oct; 24(10):1574-7. PubMed ID: 4479764
[No Abstract] [Full Text] [Related]
9. [The mechanism of coronary dilatating action of nifedipine].
Kosche F; Raff WK; Lochner W
Arzneimittelforschung; 1972 Jan; 22(1):39-42. PubMed ID: 5066996
[No Abstract] [Full Text] [Related]
10. Inotropic effects of Nifedipine: a new coronary dilating agent.
Strauer BE
Int J Clin Pharmacol; 1974 Mar; 9(2):101-7. PubMed ID: 4827553
[No Abstract] [Full Text] [Related]
11. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
[No Abstract] [Full Text] [Related]
12. The incidence and relative frequencies of congenital heart disease in school children aged 7 to 16 in Shiga Prefecture.
Hayase S; Hirakawa S; Hosokawa S; Mori N; Ito H
Jpn Circ J; 1971 Aug; 35(8):903-14. PubMed ID: 5171691
[No Abstract] [Full Text] [Related]
13. [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].
Grün G; Fleckenstein A
Arzneimittelforschung; 1972 Feb; 22(2):334-44. PubMed ID: 4623697
[No Abstract] [Full Text] [Related]
14. [Effect of BAY a 1040 on oxygen supply of the isolated perfused and arrested guinea pig heart].
Follert EK
Arzneimittelforschung; 1972 Feb; 22(2):349-53. PubMed ID: 5067486
[No Abstract] [Full Text] [Related]
15. [Effect of puerarin on coronary collateral circulation in dogs with experimental acute myocardial infarction].
Liu Q; Wang L; Lu Z; Li S; Xiong Y
Zhongguo Zhong Yao Za Zhi; 1999 May; 24(5):304-6, 320. PubMed ID: 12205891
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).
Takenaka T; Usuda S; Nomura T; Maeno H; Sado T
Arzneimittelforschung; 1976; 26(12):2172-8. PubMed ID: 1037267
[TBL] [Abstract][Full Text] [Related]
17. Cardiohemodynamic effects of BAY a 1040 in the dog.
Hashimoto K; Taira N; Chiba S; Hashimoto K; Endo M
Arzneimittelforschung; 1972 Jan; 22(1):15-21. PubMed ID: 5066992
[No Abstract] [Full Text] [Related]
18. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
Nakaya H; Kanno M
Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
[TBL] [Abstract][Full Text] [Related]
19. [Effects of furyl-dihydropyridine I on coronary collateral circulation in myocardial infarction of dogs].
Jia MJ; Chen SL; Liao YL; Liu DQ; Li LS; Zhao NP
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):462-5. PubMed ID: 7717077
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
Jolly SR; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
